Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY: ABT )

122.71 USD +1.91 (+1.58%)
Streaming Delayed Price Updated: 11:48 AM EST, Feb 24, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Abbott Laboratories

< Previous 1 2 3 4 5 6 7 8 9
...
75 76 Next >
Absolute Launches New Mobile App to Enable Customers to Secure At-Risk Endpoints Anytime, Anywhere
Absolute® (ABT.TO), a leader in Endpoint Resilience™ solutions, today announced the launch of its new Absolute Control® mobile app, designed to help customers secure endpoint devices and protect... 
From Business Wire News Releases
Abbott Receives FDA Emergency Use Authorization for its COVID-19 IgM Antibody Blood Test
- Data demonstrates highly reliable test results with 99.56% specificity and 95.00% sensitivity for patients tested 15 days after symptom onset 
From PR Newswire
Ambulatory Cardiac Monitoring Market Research and Clinical Survey Report 2020-2025: Medtronic Plc, Abbott Laboratories, Boston Scientific Corporation
Harrisburg, NC -- (SBWIRE) -- 10/08/2020 -- The report provides a detailed assessment of the 'Global Ambulatory Cardiac Monitoring Market'. This includes enabling technologies, key trends, market... 
From SBWire - Latest Press Releases
Abbott Releases ID NOW™ COVID-19 Interim Clinical Study Results from 1,003 People to Provide the Facts on Clinical Performance and to Support Public Health
- Data show ID NOW performance of 95.0% sensitivity and 97.9% specificity within seven days of symptom onset 
From PR Newswire
Quanterix Enters into a License Agreement that Grants Abbott Access to Portfolio of Bead-Based Technology Patents for Use in In Vitro Diagnostics
Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced it has entered into a non-exclusive royalty-bearing license... 
From Business Wire News Releases
Thinking about trading options or stock in AstraZeneca, Assured Guaranty, Apple, Tesla, or Abbott Laboratories?
InvestorsObserver issues critical PriceWatch Alerts for AZN, AGO, AAPL, TSLA, and ABT. 
From PR Newswire
Abbott's FreeStyle® Libre 3 System Receives CE Mark - Features World's Smallest, Thinnest Sensor with Best-in-Class Performance at the Same Low Cost for People with Diabetes
- The FreeStyle Libre 3 system automatically delivers real-time, up-to-the-minute glucose readings, unsurpassed 14-day accuracy[1] and optional glucose alarms directly to smartphones[2] for people with... 
From PR Newswire
Exciting Innovations Push the Boundaries of Healthcare's Diagnostic Abilities
FinancialBuzz.com News Commentary 
From PR Newswire
Abbott Receives CE Mark for Next-Generation MitraClip™ Heart Valve Repair Device to Treat Mitral Regurgitation
- CE Mark for MitraClip G4 offers physicians an innovative next-generation system with more options for mitral valve repair using proven clip-based technology 
From PR Newswire
Abbott Hosts Conference Call for Third-Quarter Earnings
Abbott (NYSE: ABT) will announce its third-quarter 2020 financial results on Wednesday, Oct. 21, 2020, before the market opens. 
From PR Newswire
Abbott Declares 387th Consecutive Quarterly Dividend
The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 36 cents per share. 
From PR Newswire
Abbott Introduces Libre Sense Glucose Sport Biosensor in Europe, World's First Glucose Biosensor Designed for Athletes
- Abbott's Libre Sense Glucose Sport Biosensor, with CE Mark, is built upon the company's world-leading continuous glucose monitoring technology 
From PR Newswire
New Research from Absolute Underscores Complexities, Gaps in K-12 Device and Data Security Driven by Accelerated Shift to Distance Learning
Absolute® (ABT.TO), the leader in Endpoint Resilience™ solutions, today announced new research revealing significant spikes in remote management and collaboration application usage in K-12... 
From Business Wire News Releases
Global Pain Management Devices Market Could Exceed $9 Billion By 2026
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Global Pain Management Devices Market Could Exceed $9 Billion By 2026
Financialnewsmedia.com News Commentary 
From PR Newswire
Absolute Accelerates Endpoint Resilience and Operational Agility for Customers in Era of Remote Work and Distance Learning
Absolute® (ABT.TO), the leader in Endpoint Resilience™ solutions, today announced limited-time offers for customers to purchase critical add-on capabilities, including Absolute's Application... 
From Business Wire News Releases
Abbott Announces Start of Trial to Evaluate the New Esprit™ BTK Drug-Eluting Resorbable Scaffold
- The LIFE-BTK trial will evaluate the company's new drug-eluting resorbable scaffold (DRS), known as the Esprit BTK System, for the treatment of blocked arteries below-the-knee (BTK) 
From PR Newswire
eToro Pick Healthcare Market Movers: $ABBV $ABT $AMGN
Tags The Market Signal
From The Market Signal
Absolute Named a Leader in the G2 Summer 2020 Grid Report for Endpoint Management
Absolute® (ABT.TO), the leader in Endpoint Resilience™ solutions, today announced it has been named a Leader in the Summer 2020 Grid® Report for Endpoint Management published by G2, the world’s leading... 
From Business Wire News Releases
Abbott's FreeStyle® Libre 2 iCGM System Now Available to Medicare Beneficiaries
- U.S. Centers for Medicare & Medicaid Services (CMS) reimbursement expands access of the FreeStyle Libre 2 system to Medicare patients[1] to better manage their diabetes 
From PR Newswire
Thinking about trading options or stock in Advanced Micro Devices, Inc., Abbott Laboratories, BMC Stock Holdings Inc, Nutanix Inc, or Royal Caribbean Cruises Ltd?
InvestorsObserver issues critical PriceWatch Alerts for AMD, ABT, BMCH, NTNX, and RCL. 
From PR Newswire
Medical Devices Become Widely Used as Healthcare Systems Look to Ease Burden
FinancialBuzz.com News Commentary 
From PR Newswire
Thinking about trading options or stock in Abbott Laboratories, Dollar Tree, Carnival, Tesla, or AMN Healthcare Services?
InvestorsObserver issues critical PriceWatch Alerts for ABT, DLTR, CCL, TSLA, and AMN. 
From PR Newswire
Abbott's Fast, $5, 15-Minute, Easy-to-Use COVID-19 Antigen Test Receives FDA Emergency Use Authorization; Mobile App Displays Test Results to Help Our Return to Daily Life; Ramping Production to 50 Mi
- Abbott's BinaxNOW™ COVID-19 Ag Card is a rapid, reliable, highly portable, and affordable tool for detecting active coronavirus infections at massive scale 
From PR Newswire
Absolute Announces Filing of Shelf Prospectus
Absolute Software Corporation (ABT.TO), the leader in Endpoint Resilience™ solutions, today announced that it has filed a preliminary short form base shelf prospectus with the securities regulatory... 
From Business Wire News Releases
Innovative Medical Devices Help Healthcare Systems Become More Efficient
FinancialBuzz.com News Commentary 
From PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Co-Diagnostics, Inc. of Class Action Lawsuit and Upcoming Deadline – CODX
From GlobeNewswire News Releases
Smart Diagnostic Devices Help Ease the Burden on Healthcare Systems
FinancialBuzz.com News Commentary 
From PR Newswire
Absolute Reports Fiscal 2020 Fourth Quarter and Annual Financial Results
Absolute (TSX: ABT) (“Absolute” or the “Company”), the leader in Endpoint ResilienceTM solutions, today announced its financial results for the three months and year ended June 30, 2020. All dollar... 
From Business Wire News Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Co-Diagnostics, Inc. of Class Action Lawsuit and Upcoming Deadline – CODX
From GlobeNewswire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
75 76 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.